Immune Systems

Emerging treatments & clinical trials based on how immune systems affect the development of mesothelioma cell types. Get up to date analysis.

Immune Systems | Immunotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Treatments

New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation
ByAlex Strauss March 1, 2018

Researchers at one of the nation’s top cancer institutes are betting on a combination of radiation and immunotherapy in the…

Read More New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation
Asia | Immune Systems | International | Prognosis | Research

Blood Test May Not Predict Mesothelioma Survival as Well as Hoped
ByAlex Strauss February 26, 2018

A new Japanese study is calling into question the value of a common prognostic test for people with malignant pleural…

Read More Blood Test May Not Predict Mesothelioma Survival as Well as Hoped
Immune Systems | Immunotherapy | Research | Treatments | Vaccine

Could Stem Cell Vaccine Lead to Mesothelioma Cure?
ByAlex Strauss February 15, 2018

A new stem cell vaccine that has proven effective against malignant mesothelioma and several other cancers in mice might offer…

Read More Could Stem Cell Vaccine Lead to Mesothelioma Cure?
Biomarkers | Diagnosis | Immune Systems | Immunotherapy | Research | Treatments

Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy
ByAlex Strauss November 20, 2017

A new study is casting some doubt on the value of a protein called PD-L1 as a way to select…

Read More Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy
Asbestos | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | Research | Treatments | Updates

Immunotherapy for Mesothelioma: Who Are the Best Candidates?
ByAlex Strauss November 6, 2017November 6, 2017

Immunotherapy is emerging as one of the most promising new treatment approaches for a wide range of cancers, including malignant…

Read More Immunotherapy for Mesothelioma: Who Are the Best Candidates?
Chemotherapy | Europe | Immune Systems | International | New Drugs | Research | Treatments

Three-Drug Combo is New Standard of Care for Pleural Mesothelioma in France
ByAlex Strauss November 2, 2017

France has a new standard of care for people with unresectable malignant pleural mesothelioma. Along with the chemotherapy drugs cisplatin…

Read More Three-Drug Combo is New Standard of Care for Pleural Mesothelioma in France
Asia | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | International | Prognosis | Research | Treatments

Inflammation Marker May Predict Mesothelioma Prognosis
ByAlex Strauss September 20, 2017March 19, 2019

The ratio of neutrophils to lymphocytes – a way of measuring inflammation in the body of people with malignant pleural…

Read More Inflammation Marker May Predict Mesothelioma Prognosis
Europe | Immune Systems | Immunotherapy | International | New Drugs | Prognosis | Research | Treatments

Using Immune Cells to Predict Mesothelioma Outcomes
ByAlex Strauss August 22, 2017August 23, 2017

Immune system cells may be some of the best predictors of mesothelioma outcomes, according to a group of British scientists.…

Read More Using Immune Cells to Predict Mesothelioma Outcomes
Asia | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | International | Prognosis | Research | Treatments

These Proteins Appear to Shorten Mesothelioma Survival
ByAlex Strauss August 17, 2017

New evidence suggests that mesothelioma patients whose tumors express two particular proteins do not live as long as other mesothelioma…

Read More These Proteins Appear to Shorten Mesothelioma Survival
Immune Systems | Immunotherapy | International | New Drugs | New Studies | Research | Treatments

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
ByAlex Strauss July 23, 2017

A large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant mesothelioma…

Read More Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

1 (888) 378-1331

Immune Systems

New Mesothelioma Treatment Combines Immunotherapy and Targeted Radiation

Blood Test May Not Predict Mesothelioma Survival as Well as Hoped

Could Stem Cell Vaccine Lead to Mesothelioma Cure?

Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy

Immunotherapy for Mesothelioma: Who Are the Best Candidates?

Three-Drug Combo is New Standard of Care for Pleural Mesothelioma in France

Inflammation Marker May Predict Mesothelioma Prognosis

Using Immune Cells to Predict Mesothelioma Outcomes

These Proteins Appear to Shorten Mesothelioma Survival

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES